Systematic Review of Cardiovascular Benefits and Safety of Sacubitril-Valsartan in End-Stage Kidney Disease
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference39 articles.
1. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: improving Global Outcomes (KDIGO);Herzog;Kidney Int,2011
2. Congestive heart failure in patients with chronic kidney disease and on dialysis;Schreiber;Am J Med Sci,2003
3. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients;Stack;Am J Kidney Dis,2001
4. Diagnosis and management of cardiovascular disease in advanced and end-stage renal disease;Bhatti;J Am Heart Assoc,2016
5. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade;London;Circulation,1994
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and Safety of Sacubitril/Valsartan in Hemodialysis Patients with Chronic Heart Failure: A Retrospective Study at a Single Center;Medical Science Monitor;2024-06-10
2. Ist Sacubitril/Valsartan bei fortgeschrittener Nierenerkrankung und Dialysepflichtigkeit eine gute Option?;Die Nephrologie;2024-04-09
3. Heart Failure Guideline-Directed Medical Therapy in End-Stage Kidney Disease: From PARADIGM-HF to Clinical Practice;Kidney International Reports;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3